Ara
Toplam kayıt 6, listelenen: 1-6
Glasgow coma scale and APACHE-II scores affect the liver transplantation outcomes in patients with acute liver failure
(ZHEJIANG UNIV SCH MEDICINE, 2013)
BACKGROUND: The timing and selection of patients for liver transplantation in acute liver failure are great challenges. This study aimed to investigate the effect of Glasgow coma scale (GCS) and APACHE-II scores on liver ...
Cardiac involvement of primary hyperoxaluria accompanied by non-compaction cardiomyopathy and patent ductus arteriosus
(Türk Kardioloji Derneği, 2015)
Primary hyperoxaluria is a rare hereditary metabolic disorder resulting in accumulation of calcium oxalate in visceral organs, including the heart. We report a 19-year-old male with non- compaction cardiomyopathy combined ...
The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence
(WILEY, 2016)
BackgroundThe aim of this study was to determine the long-term efficacy of nucleos(t)ide analog (NA) and low-dose hepatitis B immunoglobulin (HBIG) combination treatment for preventing post-transplant hepatitis B virus ...
Biliary complications after right lobe living donor liver transplantation: a single-centre experience
(ELSEVIER SCI LTD, 2012)
Background: Biliary complications that developed after right lobe liver transplantation from living donors were studied in a single centre. Methods: From 2004 to 2010, 200 consecutive living donor right lobe liver ...
Hepatic Arterial Mapping by Multidetector Computed Tomographic Angiography in Living Donor Liver Transplantation
(LIPPINCOTT WILLIAMS & WILKINS, 2009)
Purpose: Our aims were to present the hepatic arterial variations that were detected with computed tomographic angiography (CTA) and confirmed by operation in living liver donors and to emphasize the usefulness of CTA in ...
Liver transplantation for combined hepatocellular-cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis
(Wiley, 2021)
Introduction: Combined hepatocellular-cholangiocarcinoma is rare and comprises features of hepatocellular carcinoma and cholangiocarcinoma. The treatment of choice has not yet been defined. The aim of the study was to ...